Related Experiment Video
Updated: May 3, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Effect of hyperthyroidism on the hypercoagulable state and thromboembolic events in patients with atrial fibrillation
Qingxing Chen1, Yan Yan, Lei Zhang
1Department of Cardiology, Zhongshan Hospital, Shanghai Institute of Cardiovascular Diseases, Shanghai, China.
Insights
Hyperthyroidism (HT) in atrial fibrillation (AF) patients increases blood clot risk and stroke. This study found HT significantly elevates D-dimer levels, indicating a hypercoagulable state and higher ischemic stroke incidence in AF patients.
Area of Science:
- Cardiology
- Endocrinology
- Neurology
Background:
- Atrial fibrillation (AF) is a known risk factor for ischemic stroke.
- Hyperthyroidism (HT) can affect cardiovascular function and coagulation.
- The combined effect of HT and AF on hypercoagulability and stroke risk requires further investigation.
Purpose of the Study:
- To determine if hyperthyroidism (HT) exacerbates the hypercoagulable state and increases ischemic stroke risk in patients with atrial fibrillation (AF).
Main Methods:
- Prospective evaluation of plasma D-dimer levels and thromboembolic events in three patient groups: hyperthyroid AF (n=62), nonthyroid AF (n=107), and HT without AF (n=100).
- Plasma D-dimer levels were used as a marker for the hypercoagulable state.
- A 3-year follow-up period was employed to assess thromboembolic events.
Main Results:
- Patients with hyperthyroid AF exhibited significantly higher D-dimer levels compared to both nonthyroid AF and HT without AF groups (p < 0.001).
- The incidence of ischemic stroke was significantly higher in the hyperthyroid AF group over 3 years (HR: 3.2, p = 0.04).
- Independent predictors for ischemic stroke included age, CHADS2-VAS score, and anticoagulation status.
Conclusions:
- Hyperthyroidism (HT) appears to potentiate the hypercoagulable state in patients with atrial fibrillation (AF).
- HT may contribute to an increased risk of ischemic stroke in patients with AF.
- Further research is warranted to elucidate the mechanisms and clinical implications.
Objective:
To clarify whether hyperthyroidism (HT) itself confers an additional effect on the hypercoagulable state and the risk of ischemic stroke among patients with hyperthyroid atrial fibrillation (AF).
Methods:
We prospectively evaluated plasma D-dimer levels and thromboembolic events among three groups of patients (hyperthyroid AF, n = 62; nonthyroid AF, n = 107, and HT without AF, n = 100). Plasma D-dimer levels were used to evaluate the hypercoagulable state.
Results:
The D-dimer level was significantly higher in patients with hyperthyroid AF than in nonthyroid AF (0.66 ± 0.06 vs. 0.34 ± 0.02 mg/l, p < 0.001) and HT without AF (0.66 ± 0.06 vs. 0.27 ± 0.02 mg/l, p < 0.001). During a 3-year follow-up, patients with hyperthyroid AF had a significantly higher incidence of ischemic stroke compared with patients with nonthyroid AF (hazard ratio, HR: 3.2, 95% confidence interval, CI: 1.01-5.59, p = 0.04). Cox regression analysis revealed that age (HR: 2.5, 95% CI: 1.01-1.21, p = 0.05), CHADS2-VAS score (HR: 5.5, 95% CI: 1.51-7.43, p = 0.01) and anticoagulation (HR: 0.45, 95% CI: 0.07-0.54, p = 0.01) were independent predictors of risk for the occurrence of ischemic stroke.
Conclusions:
The present study suggests that HT may enhance the hypercoagulable state and the risk of ischemic stroke in patients with AF.
Related Concept Videos
Hyperthyroidism II: Pathophysiology
Hyperthyroidism I: Introduction
Graves Disease II: Pathophysiology
Graves' Disease I: Introduction
Hypothyroidism II: Pathophysiology
Anticoagulant Drugs: Low-Molecular-Weight Heparins

